Francesco Dentali1, Olga Nigro2, Alessandro Squizzato3, Monica Gianni4, Francesca Zuretti3, Anna Maria Grandi3, Luigina Guasti3. 1. Department of Medicine and Surgery, Insubria University, Varese, Italy. Electronic address: fdentali@libero.it. 2. Department of Oncology, Ospedale di Circolo, Varese, Italy. 3. Department of Medicine and Surgery, Insubria University, Varese, Italy. 4. Cardiology Unit, Hospital of Tradate, Tradate, Italy.
Abstract
BACKGROUND: Inflammatory markers are significantly associated with cardiovascular disease. The ratio between neutrophils and lymphocytes (NLR) is a potential new biomarker, which can single out individuals at risk for future cardiovascular events. Among total white blood cell count (WBC) and its subtypes, NLR seems to have the greatest predictive value for death and major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS). We conducted a meta-analysis of the literature to assess the relation between NLR and cardiovascular outcomes in STEMI/NSTEMI patients. METHODS: MEDLINE and EMBASE databases were searched. Two reviewers selected studies and extracted data. Pooled results were reported as odds ratios (ORs) and were presented with the corresponding 95% confidence intervals (CI). RESULTS: Twenty-three studies for a total of >16,000 patients were included. Compared to those with low NLR, high NLR on-admission was associated with a higher overall mortality both in patients with STEMI (OR: 4.60, 95% CI: 2.84-7.45; P < 0.00001) and in patients with NSTEMI (OR: 6.41, 95% CI: 2.65-15.50; P < 0.00001). An increased MACE risk was found in STEMI patients with high NLR (OR: 3.71, 95% CI: 2.67-5.17; P < 0.00001). Post-PCI mortality risk was significantly increased in patients with high NLR (OR: 3.76, 95% CI: 2.64-5.34; P < 0.00001). CONCLUSIONS: In this large meta-analysis on prognostic significance of NLR in ACS we found that on-admission high NLR in patients with STEMI/NSTEMI appeared to affect clinically important outcomes including both in-hospital and long-term mortality and MACE.
BACKGROUND: Inflammatory markers are significantly associated with cardiovascular disease. The ratio between neutrophils and lymphocytes (NLR) is a potential new biomarker, which can single out individuals at risk for future cardiovascular events. Among total white blood cell count (WBC) and its subtypes, NLR seems to have the greatest predictive value for death and major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS). We conducted a meta-analysis of the literature to assess the relation between NLR and cardiovascular outcomes in STEMI/NSTEMI patients. METHODS: MEDLINE and EMBASE databases were searched. Two reviewers selected studies and extracted data. Pooled results were reported as odds ratios (ORs) and were presented with the corresponding 95% confidence intervals (CI). RESULTS: Twenty-three studies for a total of >16,000 patients were included. Compared to those with low NLR, high NLR on-admission was associated with a higher overall mortality both in patients with STEMI (OR: 4.60, 95% CI: 2.84-7.45; P < 0.00001) and in patients with NSTEMI (OR: 6.41, 95% CI: 2.65-15.50; P < 0.00001). An increased MACE risk was found in STEMI patients with high NLR (OR: 3.71, 95% CI: 2.67-5.17; P < 0.00001). Post-PCI mortality risk was significantly increased in patients with high NLR (OR: 3.76, 95% CI: 2.64-5.34; P < 0.00001). CONCLUSIONS: In this large meta-analysis on prognostic significance of NLR in ACS we found that on-admission high NLR in patients with STEMI/NSTEMI appeared to affect clinically important outcomes including both in-hospital and long-term mortality and MACE.
Authors: Teeranan Angkananard; Thunyarat Anothaisintawee; Mark McEvoy; John Attia; Ammarin Thakkinstian Journal: Biomed Res Int Date: 2018-11-11 Impact factor: 3.411
Authors: Jan Larmann; Jessica Handke; Anna S Scholz; Sarah Dehne; Christoph Arens; Hans-Jörg Gillmann; Florian Uhle; Johann Motsch; Markus A Weigand; Henrike Janssen Journal: BMC Cardiovasc Disord Date: 2020-05-18 Impact factor: 2.298
Authors: Miao Hou; Lei Cao; Yueyue Ding; Ye Chen; Bo Wang; Jie Shen; Wanping Zhou; Jie Huang; Qiuqin Xu; Haitao Lv; Ling Sun Journal: Front Pediatr Date: 2021-05-19 Impact factor: 3.418